Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722272 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket



Drugs of Tomorrow 2000: Prostate Cancer - Hormonals and Beyond
Datamonitor, Jan 2001


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

The prostate cancer R&D pipeline is showing a swing toward innovative therapies and away from the current standard of hormonal treatments where there is limited scope for increases in efficacy. If these new therapies are able to penetrate the market, it could soon be one of the most active areas of cancer therapy research. Drugs of Tomorrow 2000: Prostate Cancer - Hormonals and Beyond provides an in-depth analysis of the prostate cancer pipeline, and a competitive analysis of the most promising classes and drugs in development. The report enables you to competitively position your products, strengthen your marketing strategy and market penetration, expose potential threats to your business and target R&D resources more effectively.



Customers who bought this item also bought

Br Malls Participacoes Sa

Br. Holdings Corporation

Drugs of Tomorrow: Cancer Overview

Drugs of Tommorow 2002: Breast Cancer

Pipeline Insight: Prostate Cancer - Domination By The Innovative Classes

Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovatives compliment traditional chemotherapies

Drugs of Tomorrow 2001: Cancer Overview

Treatment Algorithms 2001: Prostate Cancer

Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline Facing Chronic Unmet Needs

Drugs of Tomorrow 2000: Lung Cancer - New Partners For Old Regimens

Market Dynamics 2001: Hormonals

Strategic Perspectives: Prostate Cancer - Issues in Second-line, Brachytherapy and Hormone-Refractory Prostate Cancer Treatments



Top of page


   All rights reserved. � Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds